Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leiurus quinquestriatus venom neurotoxins are a diverse group of potent peptides derived from the Deathstalker scorpion, primarily functioning as high-affinity modulators of various ion channels. These toxins, which include chlorotoxin, charybdotoxin, and scyllatoxin, selectively bind to and block voltage-gated sodium, potassium, and chloride channels, as well as calcium-activated potassium channels (1.1.2, 1.4.3). Chlorotoxin has gained significant therapeutic interest due to its ability to specifically target glioma cells by binding to chloride channels and matrix metalloproteinase-2 (MMP-2), leading to the development of tumor-imaging agents like tozuleristide and targeted radiotherapeutics like 131I-TM601 (1.1.3, 1.2.1, 1.4.1). Other toxins in the venom, such as charybdotoxin, serve as valuable pharmacological tools for studying potassium channel physiology and are being explored as templates for treating autoimmune diseases and epilepsy (1.3.1, 1.3.3). While these neurotoxins are highly lethal in their natural state, causing systemic paralysis and cardiovascular distress, their exceptional specificity makes them important leads for drug discovery and diagnostic applications in oncology and neurology (1.1.2, 1.4.4).
Blockade of voltage-gated and ligand-gated ion channels (Sodium, Potassium, Chloride) and inhibition of matrix metalloproteinase-2 (MMP-2); neutralization by anti-venom antibodies.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leiurus quinquestriatus venom neurotoxins (LqTx).